Core Scientific Tranche 2 Equity Warrants (expiring January 23, 2029) have reached an all-time high, trading at $25.31. This milestone underscores the company's significant growth over the past year.
The warrants have seen a 1-year change of 133.43%, closely tracking the underlying company’s 135% annual return. With a beta of 5.45, the stock exhibits significantly higher volatility than the broader market.
This increase reflects investor confidence and optimism about Core Scientific's future prospects. The company's market capitalization has risen to $7.89 billion. As the company continues to innovate and expand, its stock performance remains a key focus for stakeholders.
